Literature DB >> 17395904

Anticoagulation for venous thromboembolism.

John W Eikelboom, Jeffrey S Ginsberg, Jack Hirsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17395904      PMCID： PMC1839231          DOI： 10.1136/bmj.39161.665579.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

Authors:  G Agnelli; P Prandoni; M G Santamaria; P Bagatella; A Iorio; M Bazzan; M Moia; G Guazzaloca; A Bertoldi; C Tomasi; G Scannapieco; W Ageno
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

Review 2.  New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism.

Authors:  Sam Schulman; Mats Ogren
Journal:  Thromb Haemost       Date:  2006-09       Impact factor: 5.249

Review 3.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

Authors:  Giancarlo Agnelli; Paolo Prandoni; Cecilia Becattini; Mauro Silingardi; Maria Rita Taliani; Maddalena Miccio; Davide Imberti; Renzo Poggio; Walter Ageno; Enrico Pogliani; Fernando Porro; Pietro Zonzin
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

5.  Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.

Authors:  I A Campbell; D P Bentley; R J Prescott; P A Routledge; H G M Shetty; I J Williamson
Journal:  BMJ       Date:  2007-02-08

6.  Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.

Authors:  Lori-Ann Linkins; Peter T Choi; James D Douketis
Journal:  Ann Intern Med       Date:  2003-12-02       Impact factor: 25.391
  6 in total
  1 in total

Review 1.  Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants.

Authors:  Raj Patel
Journal:  Int J Gen Med       Date:  2016-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.